双相障碍两个队列的脑脊液蛋白质组学研究
该探索性蛋白质组学研究分析了两个独立队列中情绪稳定双相障碍患者与对照的脑脊液201种蛋白质,共204例患者和144例对照。质控后105种蛋白质纳入分析,仅关注跨队列重复的病例对照差异。结果显示两个队列中双相障碍患者脑脊液生长激素浓度均低于对照,效应量在仅限双相I型与对照时更大;未发现免疫激活或其他异常的迹象。
要点
- 两个独立队列中,双相障碍患者脑脊液生长激素浓度均低于对照。
- 仅限双相I型与对照分析时,生长激素差异的效应量更大。
- 未发现免疫激活或其他异常的迹象。
核心结论
- 两个独立队列中双相障碍患者脑脊液生长激素浓度均低于对照,提示生长激素可能参与双相障碍的病理生理。
研究设计与样本
- 探索性蛋白质组学研究,分析两个独立队列情绪稳定双相障碍患者与对照的脑脊液样本,共204例患者和144例对照,使用三个Olink Multiplex面板(其中一个靶向免疫生物标志物)检测201种蛋白质。
主要发现
- 经质控并剔除低检出率蛋白质后,105种蛋白质纳入病例对照状态及临床变量分析,仅考虑跨队列重复的病例对照差异。
- 调整潜在混杂因素后,两个队列中双相障碍患者脑脊液生长激素浓度均低于对照。
- 仅限双相I型与对照分析时,生长激素差异的效应量更大。
- 未发现免疫激活或其他异常的迹象。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The pathophysiology of bipolar disorder remains to be elucidated and there are no diagnostic or prognostic biomarkers for the condition. In this explorative proteomic study, we analyzed 201 proteins in cerebrospinal fluid (CSF) from mood stable bipolar disorder patients and control subjects sampled from two independent cohorts, amounting to a total of 204 patients and 144 controls. We used three Olink Multiplex panels, whereof one specifically targets immune biomarkers, to assess a broad set of CSF protein concentrations. After quality control and removal of proteins with a low detection rate, 105 proteins remained for analyses in relation to case-control status and clinical variables. Only case-control differences that replicated across cohorts were considered. Results adjusted for potential confounders showed that CSF concentrations of growth hormone were lower in bipolar disorder compared with controls in both cohorts. The effect size was larger when the analysis was restricted to bipolar disorder type 1 and controls. We found no indications of immune activation or other aberrations. Growth hormone exerts many effects in the central nervous system and our findings suggest that growth hormone might be implicated in the pathophysiology of bipolar disorder.
引用
- Isgren A, Göteson A, Holmén-Larsson J, et al. Cerebrospinal fluid proteomic study of two bipolar disorder cohorts. Mol Psychiatry. 2022. PMID: 35986174. doi:10.1038/s41380-022-01724-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。